DTC spend down 3% in '07

Share this article:
Drug industry spend on consumer advertising dropped 3% in 2007 to $5.15 billion, from $5.31 billion in 2006, but spending on product advertising, particularly TV and print, continued to climb. 

Pharmas cut back sharply on corporate advertising—from $577 million in 2006 to $247 million in 2007, according to TNS Media Intelligence. But product advertising was up 3% to $4.9 billion, from $4.73 billion in 2006. 

For product advertising, newspapers took a hit as spending was halved, to $75 million from $152 million. Radio spend fell 45%, from $55 million to $30 million. Perhaps most remarkably, Internet spending slid 5%, from $163 million to $155 million, though that figure reflects display advertising—not spend on search engine optimization or websites. 

Spending on TV product ads rose 7% to $2.87 billion from $2.66 billion in 2006, while spending on product ads in magazines climbed 4% to $1.76 billion from $1.68 billion in 2006.

The numbers suggest that pharmas are still leaning heavily on mass-market “shotgun” channels to drive awareness of the products, but that marketers, under pressure to cut costs, are trimming where they can. Overall spend has seen steady increases for a decade, but some spending may be shifting toward less-measurable means of reaching consumers, such as websites and online CRM. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?